Search

Vasant K Manna

from Ewing, NJ
Age ~77
Get Report
Related to:
Sradha Manna, 68
Connected to:
Andy A Manna, 66Carmine V Manna, 63Dean R Manna, 78Donna J Manna, 65Erin C Manna, 36Frederick J Manna, 75Kuntal Manna, 42Lasaundra A Manna, 46Leonard L Manna, 68Lucia Manna, 99

Vasant Manna Phones & Addresses

  • 40 Colleen Cir, Trenton, NJ 08638
  • Ewing, NJ
  • 253 Nassau St, Princeton, NJ 08540
  • Cranbury, NJ

Work

Company: Vasantmanna Jul 2014 Position: Independent consultant

Skills

Therapeutic Areas • Drug Development • Immunology • Ctms • Cro • Gcp • Clinical Trials • Medical Writing • Internal Medicine • Regulatory Affairs • Market Access • Regulatory Submissions • Ich Gcp • Clinical Monitoring • Pharmaceutical Industry • Medical Affairs • Translational Medicine • Clinical Operations • Edc • Clinical Research • Medicine

Languages

English • French

Industries

Pharmaceuticals

Resumes

Resumes

Vasant Manna Photo 1

Independent Consultant

View page
Location:
Princeton, NJ
Industry:
Pharmaceuticals
Work:
Vasantmanna
Independent Consultant
Galderma Jul 2009 - Jul 2014
Senior Medical Advisor and Project Leader
Galderma Feb 2006 - Jul 2009
Senior Clinical Project Manager
Bristol-Myers Squibb Jan 1996 - Jan 2006
Director Immunology and Dermatology
Gsk 1992 - 1995
Clinical Research Physician
Skills:
Therapeutic Areas
Drug Development
Immunology
Ctms
Cro
Gcp
Clinical Trials
Medical Writing
Internal Medicine
Regulatory Affairs
Market Access
Regulatory Submissions
Ich Gcp
Clinical Monitoring
Pharmaceutical Industry
Medical Affairs
Translational Medicine
Clinical Operations
Edc
Clinical Research
Medicine
Languages:
English
French

Publications

Us Patents

Method Of Treating Acne

View page
US Patent:
20130196954, Aug 1, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/802371
Inventors:
Vasant Kumar MANNA - Ewing NJ, US
Sandrine SEGURA - Biot, FR
Ludovic BUSSARD - Saint-Girod, FR
Jean-Pierre ETCHEGARAY - Nice, FR
Phil FREIDENREICH - Yardley PA, US
International Classification:
A61K 9/00
A61K 31/65
US Classification:
514152
Abstract:
An improved method for treating acne is described. The method involves 16-week, once daily, oral administration of about 40 mg doxycycline in a pharmaceutical composition containing about 30 mg doxycycline in an immediate release portion and about 10 mg doxycycline in a delayed release portion. It was surprisingly discovered that the 16-week, once daily, oral administration of about 40 mg doxycycline has achieved same or superior efficacy than that of 100 mg doxycycline, but with a significant reduction in adverse events.

Combination Of Adapalene And Benzoyl Peroxide For The Treatment Of Severe Acne

View page
US Patent:
20170216231, Aug 3, 2017
Filed:
Jul 16, 2015
Appl. No.:
15/329170
Inventors:
- Biot, FR
Michael GRAEBER - Lawrenceville NJ, US
Vasant MANNA - Ewing NJ, US
International Classification:
A61K 31/192
A61K 9/06
A61K 9/00
A61K 31/327
Abstract:
The present invention concerns a pharmaceutical composition comprising 0.3% by weight of adapalene or a pharmaceutically acceptable salt thereof and 2.5% by weight of benzoyl peroxide, as active ingredients, for its use by topical administration in the treatment of inflammatory acne lesions. The present invention further concerns regimen for the therapeutic treatment of acne lesions in subjects afflicted with severe acne. The regimen includes topically applying to a subject's skin, as active ingredients, 0.3% by weight adapalene and 2.5% by weight benzoyl peroxide, combined in a single formula that delivers the active ingredients together. The single formula can for example be applied once or twice daily for a period of 8 to 12 weeks.

Combination Of Adapalene And Benzoyl Peroxide For The Treatment Of Severe Acne

View page
US Patent:
20170095434, Apr 6, 2017
Filed:
Dec 19, 2016
Appl. No.:
15/383675
Inventors:
- Biot, FR
Michael GRAEBER - Lawrenceville NJ, US
Vasant MANNA - Ewing NJ, US
International Classification:
A61K 31/192
A61K 9/00
A61K 47/34
A61K 47/26
A61K 47/10
A61K 31/327
A61K 9/06
Abstract:
The present invention concerns a pharmaceutical composition comprising 0.3% by weight of adapalene or a pharmaceutically acceptable salt thereof and 2.5% by weight of benzoyl peroxide, as active ingredients, for its use by topical administration in the treatment of inflammatory acne lesions. The present invention further concerns regimen for the therapeutic treatment of acne lesions in subjects afflicted with severe acne. The regimen includes topically applying to a subject's skin, as active ingredients, 0.3% by weight adapalene and 2.5% by weight benzoyl peroxide, combined in a single formula that delivers the active ingredients together. The single formula can for example be applied once or twice daily for a period of 8 to 12 weeks.

Treatment Of Preadolescent Moderate Acne Vulgaris

View page
US Patent:
20150126608, May 7, 2015
Filed:
May 24, 2013
Appl. No.:
14/397728
Inventors:
- Biot, FR
Zoe D. Draelos - High Point NC, US
Anne W. Lucky - Cincinnati OH, US
Adelaide A. Herbert - Houston TX, US
Jeffrey Sugarman - Santa Rosa CA, US
Linda Stein Gold - Bloomfield Hills MI, US
Diane Rudisill - Princeton Junction NJ, US
Hong Liu - Perrineville NJ, US
Vasant Manna - Ewing NJ, US
International Classification:
A61K 31/327
A61K 9/00
A61K 47/10
A61K 47/26
A61K 47/20
A61K 31/192
A61K 47/32
US Classification:
514569
Abstract:
A method of treating preadolescent acne is described. The method can include administering an effective amount of a pharmaceutical composition that includes a fixed combination of adapalene and benzol peroxide to a preadolescent patient in need thereof.The preadolescent patient can be from age 7 to age 11, and the pharmaceutical composition can include from 0.01% to 2% by weight of adapalene and from 0.1% to 5% by weight by weight of benzol peroxide.Also described, is a composition for use in such a method.

Method Of Treating Acne

View page
US Patent:
20140309198, Oct 16, 2014
Filed:
Apr 4, 2014
Appl. No.:
14/245666
Inventors:
Vasant Kumar MANNA - Ewing NJ, US
Sandrine SEGURA - Biot, FR
Ludovic BUSSARD - Saint-Girod, FR
Jean-Pierre ETCHEGARAY - Nice, FR
Philip FREIDENREICH - Yardley PA, US
International Classification:
A61K 9/48
A61K 9/28
A61K 31/65
US Classification:
514152
Abstract:
An improved method for treating acne is described. The method involves 16-week, once daily, oral administration of about 40 mg doxycycline in a pharmaceutical composition containing about 30 mg doxycycline in an immediate release portion and about 10 mg doxycycline in a delayed release portion. It was surprisingly discovered that the 16-week, once daily, oral administration of about 40 mg doxycycline has achieved same or superior efficacy than that of 100 mg doxycycline, but with a significant reduction in adverse events.
Control profile
Vasant K Manna from Ewing, NJ, age ~77 Get Report